Giuseppe Viscardi

COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study

Marina Chiara Garassino, Jennifer G. Whisenant, Li‐Ching Huang et al. · The Lancet Oncology · 2020 · 621 citations · Full text

Virus Epidemiology, Medicine, Covid-19 Pandemic +12

EPSILoN: A Prognostic Score for Immunotherapy in Advanced Non-Small-Cell Lung Cancer: A Validation Cohort

Arsela Prelaj, Roberto Ferrara, Sara Elena Rebuzzi et al. · Cancers · 2019 · 77 citations · Full text

Immunology, Immunotherapeutics, Immunotherapy +21

Results of the safety run-in part of the METAL (METformin in Advanced Lung cancer) study: a multicentre, open-label phase I–II study of metformin with erlotinib in second-line therapy of patients with stage IV non-small-cell lung cancer

Floriana Morgillo, Morena Fasano, Carminia Maria Della Corte et al. · ESMO Open · 2017 · 74 citations · Full text

Evaluation of Major Pathologic Response and Pathologic Complete Response as Surrogate End Points for Survival in Randomized Controlled Trials of Neoadjuvant Immune Checkpoint Blockade in Resectable in NSCLC

Jacobi Hines, Robert B. Cameron, A. Esposito et al. · Journal of Thoracic Oncology · 2024 · 62 citations · Full text

TERAVOLT: Thoracic Cancers International COVID-19 Collaboration

Jennifer G. Whisenant, Annalisa Trama, Valter Torri et al. · Cancer Cell · 2020 · 59 citations · Full text

Medicine, Oncology, Radiation Oncology +5